메뉴 건너뛰기




Volumn 10, Issue 1, 2007, Pages 95-101

Clinical presentation and response to therapy in patients with massive prolactin hypersecretion

Author keywords

Cabergoline; Macroprolactinoma; Pituitary adenoma; Prolactin

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; HYDROCORTISONE; PROLACTIN; TESTOSTERONE;

EID: 34147112247     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-007-0009-y     Document Type: Article
Times cited : (8)

References (27)
  • 1
    • 0034850405 scopus 로고    scopus 로고
    • Disorders of prolactin secretion
    • Molitch ME (2001) Disorders of prolactin secretion. Endocrinol Metab Clin North Am 30(3):585-610
    • (2001) Endocrinol Metab Clin North Am , vol.30 , Issue.3 , pp. 585-610
    • Molitch, M.E.1
  • 2
    • 0032961611 scopus 로고    scopus 로고
    • The pathology of pituitary tumors
    • Asa SL (1999) The pathology of pituitary tumors. Endocrinol Metab Clin North Am 28(1):13-vi
    • (1999) Endocrinol Metab Clin North Am , vol.28 , Issue.1
    • Asa, S.L.1
  • 4
    • 0036328386 scopus 로고    scopus 로고
    • Giant prolactinomas: Clinical management and long-term follow up
    • Shrivastava RK, Arginteanu MS, King WA, Post KD (2002) Giant prolactinomas: Clinical management and long-term follow up. J Neurosurg 97(2):299-306
    • (2002) J Neurosurg , vol.97 , Issue.2 , pp. 299-306
    • Shrivastava, R.K.1    Arginteanu, M.S.2    King, W.A.3    Post, K.D.4
  • 5
    • 0032531231 scopus 로고    scopus 로고
    • Management of pituitary tumors
    • Shimon I, Melmed S (1998) Management of pituitary tumors. Ann Intern Med 129(6):472-483
    • (1998) Ann Intern Med , vol.129 , Issue.6 , pp. 472-483
    • Shimon, I.1    Melmed, S.2
  • 6
    • 0021347129 scopus 로고
    • Rapid size reduction of giant prolactinoma following medical treatment
    • Perani D, Colombo N, Scotti G, Tonon C (1984) Rapid size reduction of giant prolactinoma following medical treatment. J Comput Assist Tomogr 8(1):131-133
    • (1984) J Comput Assist Tomogr , vol.8 , Issue.1 , pp. 131-133
    • Perani, D.1    Colombo, N.2    Scotti, G.3    Tonon, C.4
  • 7
    • 0030019740 scopus 로고    scopus 로고
    • High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas
    • St Jean E, Blain F, Comtois R (1996) High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas. Clin Endocrinol (Oxf) 44(3):305-309
    • (1996) Clin Endocrinol (Oxf) , vol.44 , Issue.3 , pp. 305-309
    • St Jean, E.1    Blain, F.2    Comtois, R.3
  • 8
    • 0031946789 scopus 로고    scopus 로고
    • Pituitary adenomas secreting large amounts of prolactin may give false low values in immunoradiometric assays. The hook effect
    • Petakov MS, Damjanovic SS, Nikolic-Durovic MM, et al (1998) Pituitary adenomas secreting large amounts of prolactin may give false low values in immunoradiometric assays. The hook effect. J Endocrinol Invest 21(3):184-188
    • (1998) J Endocrinol Invest , vol.21 , Issue.3 , pp. 184-188
    • Petakov, M.S.1    Damjanovic, S.S.2    Nikolic-Durovic, M.M.3
  • 9
    • 0034649388 scopus 로고    scopus 로고
    • Giant prolactinoma and hook effect
    • Pakzaban P (2000) Giant prolactinoma and hook effect. Neurology 55(9):1415-1416
    • (2000) Neurology , vol.55 , Issue.9 , pp. 1415-1416
    • Pakzaban, P.1
  • 11
    • 0031753687 scopus 로고    scopus 로고
    • Surgical indication after bromocriptine therapy on giant prolactinomas: Effects and limitations of the medical treatment
    • Saeki N, Nakamura M, Sunami K, Yamaura A (1998) Surgical indication after bromocriptine therapy on giant prolactinomas: Effects and limitations of the medical treatment. Endocr J 45(4):529-537
    • (1998) Endocr J , vol.45 , Issue.4 , pp. 529-537
    • Saeki, N.1    Nakamura, M.2    Sunami, K.3    Yamaura, A.4
  • 12
  • 13
    • 0032964305 scopus 로고    scopus 로고
    • Medical treatment of prolactinomas
    • vii
    • Molitch ME (1999) Medical treatment of prolactinomas. Endocrinol Metab Clin North Am 28(1):143-69, vii
    • (1999) Endocrinol Metab Clin North Am , vol.28 , Issue.1 , pp. 143-169
    • Molitch, M.E.1
  • 14
    • 0036774377 scopus 로고    scopus 로고
    • The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma
    • Gillam MP, Middler S, Freed DJ, Molitch ME (2002) The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma. J Clin Endocrinol Metab 87(10):4447-4451
    • (2002) J Clin Endocrinol Metab , vol.87 , Issue.10 , pp. 4447-4451
    • Gillam, M.P.1    Middler, S.2    Freed, D.J.3    Molitch, M.E.4
  • 15
    • 0024799025 scopus 로고
    • Long-term treatment with a new repeatable injectable form of bromocriptine, Parlodel LAR, in patients with tumorous hyperprolactinemia
    • Ciccarelli E, Miola C, Avataneo T, Camanni F, Besser GM, Grossman A (1989) Long-term treatment with a new repeatable injectable form of bromocriptine, Parlodel LAR, in patients with tumorous hyperprolactinemia. Fertil Steril 52(6):930-935
    • (1989) Fertil Steril , vol.52 , Issue.6 , pp. 930-935
    • Ciccarelli, E.1    Miola, C.2    Avataneo, T.3    Camanni, F.4    Besser, G.M.5    Grossman, A.6
  • 16
    • 0025272634 scopus 로고
    • Giant invasive prolactinoma: A case report and review of nine further cases
    • Davis JR, Sheppard MC, Heath DA (1990) Giant invasive prolactinoma: A case report and review of nine further cases. Q J Med 74(275):227-238
    • (1990) Q J Med , vol.74 , Issue.275 , pp. 227-238
    • Davis, J.R.1    Sheppard, M.C.2    Heath, D.A.3
  • 17
    • 0026521043 scopus 로고
    • Giant basal prolactinoma extending into the nasal cavity
    • Iwai Y, Hakuba A, Khosla VK, et al (1992) Giant basal prolactinoma extending into the nasal cavity. Surg Neurol 37(4):280-283
    • (1992) Surg Neurol , vol.37 , Issue.4 , pp. 280-283
    • Iwai, Y.1    Hakuba, A.2    Khosla, V.K.3
  • 18
    • 0026774787 scopus 로고
    • Treatment of extensively invasive (giant) prolactinomas with bromocriptine
    • Grebe SK, Delahunt JW, Feek CM (1992) Treatment of extensively invasive (giant) prolactinomas with bromocriptine. N Z Med J 105(931):129-131
    • (1992) N Z Med J , vol.105 , Issue.931 , pp. 129-131
    • Grebe, S.K.1    Delahunt, J.W.2    Feek, C.M.3
  • 19
    • 0023106074 scopus 로고
    • Testosterone-related exacerbation of a prolactin-producing macroadenoma: Possible role for estrogen
    • Prior JC, Cox TA, Fairholm D, Kostashuk E, Nugent R (1987) Testosterone-related exacerbation of a prolactin-producing macroadenoma: possible role for estrogen. J Clin Endocrinol Metab 64(2):391-394
    • (1987) J Clin Endocrinol Metab , vol.64 , Issue.2 , pp. 391-394
    • Prior, J.C.1    Cox, T.A.2    Fairholm, D.3    Kostashuk, E.4    Nugent, R.5
  • 20
    • 0034433114 scopus 로고    scopus 로고
    • Rapid re-expansion of a macroprolactinoma after early discontinuation of bromocriptine
    • Orrego JJ, Chandler WF, Barkan AL (2000) Rapid re-expansion of a macroprolactinoma after early discontinuation of bromocriptine. Pituitary 3(3):189-192
    • (2000) Pituitary , vol.3 , Issue.3 , pp. 189-192
    • Orrego, J.J.1    Chandler, W.F.2    Barkan, A.L.3
  • 22
    • 0020080133 scopus 로고
    • Bromocriptine in management of large pituitary tumours
    • Wass JA, Williams J, Charlesworth M, et al (1982) Bromocriptine in management of large pituitary tumours. Br Med J (Clin Res Ed) 284(6333):1908-1911
    • (1982) Br Med J (Clin Res Ed) , vol.284 , Issue.6333 , pp. 1908-1911
    • Wass, J.A.1    Williams, J.2    Charlesworth, M.3
  • 23
    • 0034578628 scopus 로고    scopus 로고
    • Pergolide as primary therapy for macroprolactinomas
    • Orrego JJ, Chandler WF, Barkan AL (2000) Pergolide as primary therapy for macroprolactinomas. Pituitary 3(4):251-256
    • (2000) Pituitary , vol.3 , Issue.4 , pp. 251-256
    • Orrego, J.J.1    Chandler, W.F.2    Barkan, A.L.3
  • 24
    • 0031969319 scopus 로고    scopus 로고
    • Giant pituitary prolactinoma with falsely low serum prolactin: The pitfall of the "high-dose hook effect": Case report
    • Barkan AL, Chandler WF (1998) Giant pituitary prolactinoma with falsely low serum prolactin: The pitfall of the "high-dose hook effect": Case report. Neurosurgery 42(4):913-915
    • (1998) Neurosurgery , vol.42 , Issue.4 , pp. 913-915
    • Barkan, A.L.1    Chandler, W.F.2
  • 25
    • 33644856097 scopus 로고    scopus 로고
    • Combined treatment of invasive giant prolactinomas
    • Yu C, Wu Z, Gong J (2005) Combined treatment of invasive giant prolactinomas. Pituitary 8:61-65
    • (2005) Pituitary , vol.8 , pp. 61-65
    • Yu, C.1    Wu, Z.2    Gong, J.3
  • 26
    • 33644518385 scopus 로고    scopus 로고
    • Bromocriptine treatment of invasive giant prolactinomas involving the cavernous sinus: Results of a long-term follow up
    • Wu ZB, Yu CJ, Su ZP,Shuge QC, Wu JS, Zheng WM (2006) Bromocriptine treatment of invasive giant prolactinomas involving the cavernous sinus: results of a long-term follow up. J Neurosurg 104:54-61
    • (2006) J Neurosurg , vol.104 , pp. 54-61
    • Wu, Z.B.1    Yu, C.J.2    Su, Z.P.3    Shuge, Q.C.4    Wu, J.S.5    Zheng, W.M.6
  • 27
    • 33644551298 scopus 로고    scopus 로고
    • Long-term efficacy of bromocriptine in macroprolactinomas and giant prolactinomas in men
    • Chattopadhyay A, Bhansali A, Masoodi SR (2005) Long-term efficacy of bromocriptine in macroprolactinomas and giant prolactinomas in men. Pituitary 8:147-154
    • (2005) Pituitary , vol.8 , pp. 147-154
    • Chattopadhyay, A.1    Bhansali, A.2    Masoodi, S.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.